Royce & Associates’s Alignment Healthcare ALHC Stock Holding History
Bought
Maintained
Sold
Other funds holding ALHC
Royce & Associates's ALHC Position: Q2 2026 in Review
Royce & Associates increased its Alignment Healthcare (ALHC) stake by 40% in Q2 2026, buying an estimated $4.28M and bringing the position to 780,938 shares worth $18.6M. The position accounts for 0.15% of the portfolio, ranked #224.
Royce & Associates first reported a position in ALHC in Q3 2024 and has held it in 8 quarters since. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.
- Royce & Associates held 780,938 shares of Alignment Healthcare worth $18.6M as of Q2 2026.
- Royce & Associates bought 223,000 Alignment Healthcare shares in Q2 2026, an estimated $4.28M.
- Alignment Healthcare made up 0.15% of Royce & Associates's portfolio in Q2 2026, its #224 holding.
- Royce & Associates first reported a position in Alignment Healthcare in Q3 2024 and has held it in 8 quarters since.
- 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.
Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.